Skip to main content

Table 6 Availability of recommended antidotes* stratified by hospital type (n = 18)

From: Availability of treatment resources for the management of acute toxic exposures and poisonings in emergency departments among various types of hospitals in Palestine: a cross-sectional study

Antidote list

Total

Private

Government

P-value

N = 18 (%)

N = 8 (%)

N = 10 (%)

Atropine sulphate

18 (100)

8 (100)

10 (100)

>0.999

Calcium gluconate

18 (100)

8 (100)

10 (100)

>0.999

Deferoxamine

10 (55.6)

0 (0.0)

10 (100)

0.000

Digoxin immune Fab

2 (11.1)

1 (12.5)

1 (10)

>0.999

Dimercaprol

0 (0.0)

0 (0.0)

0 (0.0)

>0.999

Ethanol (100%)

5 (27.8)

3 (37.5)

2 (20)

0.608

Fomepizole

0 (0.0)

0 (0.0)

0 (0.0)

>0.999

Glucagon

8 (44.4)

6 (75)

2 (20)

0.054

Methylene blue

7 (38.9)

2 (25)

5 (50)

0.367

N-acetylcysteine

8 (44.4)

6 (75)

2 (20)

0.054

Naloxone

17 (94.4)

8 (100)

9 (90)

>0.999

Polyvalent anti-venom

3 (16.7)

0 (0.0)

3 (30)

0.216

Pralidoxime

1 (5.6)

1 (12.5)

0 (0.0)

0.444

Pyridoxine

1 (5.6)

1 (12.5)

0 (0.0)

0.444

Sodium bicarbonate

18 (100)

8 (100)

10 (100)

>0.999

Cyanide Kit

0 (0.0)

0 (0.0)

0 (0.0)

>0.999

  1. * According to guidelines from Dart et al. antidotes [11].